Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and κ-opioid receptor agonists

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 3, 1997, Pages 449-455

  Shippenberg, Toni S ^a   Rea, William ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Opioid receptor agonists; Conditioned place preference; Dynorphin; Locomotor activity; Prodynorphin; Psychostimulants; Sensitization

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; COCAINE; DOPAMINE; DYNORPHIN[1-13]; ENDORPHIN; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; DRUG ABUSE; DRUG DEPENDENCE; ETIOLOGY; GENE EXPRESSION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; COCAINE; DYNORPHINS; LOCOMOTION; RECEPTORS, OPIOID, KAPPA;

ANIMALIA; FORMICIDAE;

EID: 0030740849     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00450-9     Document Type: Article

References (66)

1. Ackerman J. M., White F. L. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci. Lett. 117:1990;181-187.
2. Angulo J. A., Williams A., Ledoux M., Watanabe Y., McEwen B. Elevation of striatal and accumbal preproenkephalin, preprotachykinin and preprodynorphin mRNA abundance subsequent to NMDA receptor blockade with MK-801. Mol. Brain Res. 29:1995;15-22.
3. Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science. 215:1982;413-415.
4. Chen L., Gu Y., Huang L.-Y. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. 482:1995;575-581.
5. Crawford C. A., Nguyen S., Hall S. E., Berger S. P. Microdialysis and behavioral evidence of the functional antagonism of cocaine by the kappa agonist U50488. Harris:1993;55th. L. S., ed. Problems of drug dependence: Proceedings of the Annual Scientific Meeting, The College on Problems of Drug Dependence. NIDA Research Monograph 141. Rockville, MD: US Government Printing Office;:107.
6. Daunais J. B., McGinty J. F. Acute and chronic cocaine binging differentially alter striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
7. Daunais J. B., McGinty J. F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol. Brain Res. 29:1995;201-210. 1995.
8. Daunais J. B., Roberts D. C. S., McGinty J. F. Cocaine self-administration increases prodynorphin, but not c-fos mRNA in rat striatum. NeuroReport. 4:1993;543-546.
9. Devine D. P., Leone P., Pocock D., Wise R. A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release. In vivo microdialysis studies J. Pharmacol. Exp. Ther. 266:1993;1236-1246.
10. Di Chiara G., Imperato A. Opposite effects of μ- and κ-opioid agonists on dopamine release in the nucleus accumbens and dorsal caudate of freely-moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
11. Ehrman R. N., Robbins S. J., Childress A. R., O'Brian C. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology. 107:1992;523-529.
12. Heidbreder C. A., Babovic-Vuksanovic D., Shoaib M., Shippenberg T. S. Development of behavioral sensitization to cocaine. Influence of kappa opioid receptor agonists J. Pharmacol. Exp. Ther. 275:1995;150-163.
13. Heidbreder C., Goldberg S., Shippenberg T. S. The kappa opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616:1993;333-338.
14. Heidbreder C. A., Shippenberg T. S. U69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. NeuroReport. 5:1994;1797-1800.
15. Heidbreder C. A., Shippenberg T. S. κ-Agonists prevent initiation and long-term expression of behavioral sensitization to cocaine by normalizing cocaine-induced alterations in extracellular dopamine. Soc. Neurosci. Abstr. 2:1995;718.
16. Henry D. J., White F. J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:1991;882-890.
17. Horger B. A., Shelton K., Schenk S. Pre-exposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37:1990;707-711.
18. Hurd Y. L., Brown E. E., Finlay J. M., Fibiger H. C., Gerfen C. R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
19. Hurd Y. L., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
20. Jeziorski M., White F. J. Electrophysiological effects of selective opioid receptor agonists on A10 dopamine (DA) neurons. Soc. Neurosci. Abstr. 15:1989;1001.
21. Johnson S. W., Seutin V., North R. A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate. Role of electrogenic sodium pump Science. 258:1992;665-667.
22. Kalivas P. W., Alesdatter J. E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
23. Kalivas P. W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 131:1993;266-275.
24. Kalivas P. W., Stewart J. Dopamine transmission in the initiation and expression of drug and stress induced sensitization. Brain Res. Rev. 16:1991;223-244.
25. Karler R., Calder L. D., Chaudhry I. A., Turkanis S. A. Blockade of 'reverse-tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
26. Kelly P., Iversen S. D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons. Abolition of psychostimulant-induced locomotor activities in rats Eur. J. Pharmacol. 40:1986;45-56.
27. 3H]U69593, a highly selective ligand for the κ-opioid receptor. Eur. J. Pharmacol. 109:1985;281-284.
28. Lahti R. A., Von Voightlander P. F., Barsuhn C. Properties of a selective kappa agonist U-50488H. Life Sci. 31:1982;2257-2260.
29. Lett B. T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacology. 98:1989;357-362.
30. Li S. J., Jiang M. S., Stachowiak M. S., Hudson P. M., Owyan g V., Nanry K., Tilson H. A., Hong J. S. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat stratum. Mol. Brain Res. 8:1990;219-225.
31. Li S. J., Sivam S. P., Hong J. S. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system. Brain Res. 398:1986;390-392.
32. Maisonneuve I. M., Archer S., Glick S. D. U50,488, a κ opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens. Neurosci. Lett. 181:1994;57-60.
33. Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Autoradiographic differentiation of mu, delta and kappa receptors in rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
34. Millan M. H., Chapman A. G., Meldrum B. S. Dual inhibitory action of enadoline (CI977) on release of amino acids in the rat hippocampus. Eur. J. Pharmacol. 279:1995;75-81.
35. Morris B. J., Herz A., Hollt V. Localization of striatal opioid gene expression and its modulation by the mesostriatal dopamine pathway. An in situ hybridization study J. Mol. Neurosci. 1:1988;9-18.
36. Morris B. J., Hollt V., Herz A. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA. Contrasting effects of D1 and D2 antagonists Neuroscience. 25:1988;525-532.
37. Mulder A. H., Wardeh G., Hogenboom F., Frankhuyzen A. L. Selectivity of various opioid peptides towards delta-, kappa-, and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Neuropeptides. 14:1989;99-104.
38. Piazza P. V., Deminiere J. M., Le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
39. Pickel V. M., Chan J., Sesack S. R. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral area and substantia nigra. Brain Res. 692:1993;275-289.
40. Robinson T. E., Berridge K. C. The neural basis of drug-craving. An incentive-sensitization theory of addiction Brain Res. Rev. 18:1993;247-291.
41. Robledo P., Maldonado L., Koob G. F. Role of dopamine receptors in the nucleus accumbens in the rewarding properties of cocaine. Ann. N.Y. Acad. Sci. 654:1992;509-512.
42. Sala M., Braida D., Colombo M., Gropetti A., Sacco S., Gori E., Parenti M. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J. Pharmacol. Exp. Ther. 274:1995;450-457.
43. Shippenberg T. S., Heidbreder Ch. Sensitization to the conditioned rewarding effects of cocaine. Pharmacological and temporal aspects J. Pharmacol. Exp. Ther. 273:1995;808-815.
44. Shippenberg T. S., Herz A., Spanagel R., Bals-Kubik R., Stein C. Conditioning of opioid reinforcement. Neuroanatomical and neurochemical substrates Ann. N.Y. Acad. Sci. 654:1992;347-356.
45. Shippenberg T. S., LeFevour A., Heidbreder Ch. κ-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276:1996;545-554.
46. Singh N. A., Midgely L. P., Bush J. W., Hanson G. R. N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and dynorphin systems. Brain Res. 555:1991;233-238.
47. Sivam S. P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 250:1989;818-824.
48. Smiley P. L., Johnson M., Bush L., Gibb J. W., Hanson G. R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253:1990;938-943.
49. Smith A. J. W., McGinty J. F. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21:1994;359-362.
50. Spanagel R., Herz A., Shippenberg T. S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
51. Spangler R., Unterwald E. M., Kreek M. J. "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19:1993;323-327.
52. Spealman R. D., Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261:1992;637-645.
53. Spealman R. D., Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine. Comparison of mu, kappa, and delta agonists in squirrel monkeys discriminating low doses of cocaine Behav. Pharmacol. 5:1994;21-31.
54. Stewart J., Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav. Pharmacol. 4:1993;289-313.
55. Suad-Chagny M. F., Chergui K., Chouvet G., Gonon F. Relationship between dopamine release in the rat nucleus accumbens and discharge of activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience. 49:1992;63-72.
56. Ukai M., Kamiya T., Toyeshi T., Kameyama T. Systemic administration of dynorphin A. inhibits different behavioral responses induced by cocaine in the mouse Neuropharmacology. 31:1992;843-849.
57. Unterwald E. M., Rubenfeld J. M., Kreek M. J. Repeated cocaine administration upregulates κ and μ but not δ, opioid receptors. NeuroReport; 5:1994;1613-1616.
58. Van Bockstaele E., Gracy K. N., Pickel V. M. Dynorphin-immunoreactive neurons in the rat nucleus accumbens. Ultrastructure and synaptic inputs from terminals containing substance P and/or dynorphin J. Comp. Neurol. 35:1995;117-133.
59. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine. Lack of conditioned effects Brain Res. 516:1990;99-106.
60. Wang J. Q., Daunais J. B., McGinty J. F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353.
61. Wang J. Q., McGinty J. F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273:1995;909-917.
62. Weiss F., Markou A., Lorang M. T., Koob G. F. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited access self-administration. Brain Res. 593:1992;314-319.
63. Weiss F., Paulus M. P., Lorang M. T., Koob G. F. Increases in extracellular dopamine in the nucleus accumbens are inversely related to basal levels. Effects of acute and repeated administration J. Neurosci. 12:1992;4372-4380.
64. White F. J., Wang R. Y. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment. Brain Res. 309:1984;283-292.
65. Wolf M. E., White F. J., Hu X.-T. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14:1994;1735-1745.
66. Wolf M. E., White F. J., Nassar R., Brooderson R. J. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1994;249-255.